Clinical Trial Update: Efficacy and Safety of Enteric-coated Mycophenolate Sodium in Combination With Two Corticosteroid Regimens for the Treatment of Lupus Nephritis Flare [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the efficacy and safety of enteric-coated mycophenolate sodium in combination with two corticosteroid regimens for lupus nephritis flar…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lupus Nephritis

Drugs mentioned

• Enteric-coated mycophenolate sodium (mycophenolate sodium)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Lupus Nephritis | Phase 2 | Status: COMPLETED | Results posted: 2011-06-28